Induction of chronic cholestasis without liver cirrhosis - Creation of an animal model by Dondorf, Felix et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2017
Induction of chronic cholestasis without liver cirrhosis - Creation of an
animal model
Dondorf, Felix; Fahrner, René; Ardelt, Michael; Patsenker, Eleonora; Stickel, Felix; Dahmen, Uta;
Settmacher, Utz; Rauchfuß, Falk
DOI: https://doi.org/10.3748/wjg.v23.i23.4191
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-144840
Published Version
 
 
Originally published at:
Dondorf, Felix; Fahrner, René; Ardelt, Michael; Patsenker, Eleonora; Stickel, Felix; Dahmen, Uta;
Settmacher, Utz; Rauchfuß, Falk (2017). Induction of chronic cholestasis without liver cirrhosis - Creation
of an animal model. World Journal of Gastroenterology, 23(23):4191-4199.
DOI: https://doi.org/10.3748/wjg.v23.i23.4191
Felix Dondorf, René Fahrner, Michael Ardelt, Uta Dahmen, 
Utz Settmacher, Falk Rauchfuß, Department of General, 
Visceral and Vascular Surgery, Jena University Hospital, 07747 
Jena, Germany
Eleonora Patsenker, Felix Stickel, Division of Gastroenterology 
and Hepatology, University Hospital Zürich, 8091 Zürich, 
Switzerland
Author contributions: Dondorf F, Settmacher U and Rauchfuß 
F designed the study; Dondorf F, Fahrner R, Patsenker E, Stickel 
F, Dahmen U and Rauchfuß F performed the data acquisition; 
Dondorf F, Settmacher U and Rauchfuß F analyzed the data; 
Dondorf F and Rauchfuß F wrote the paper; Fahrner R, Ardelt M, 
Settmacher U and Rauchfuß F revised the paper.
Institutional review board statement: Since this study is an 
animal research project, an institutional review board statement is 
not needed in our institution.
Institutional animal care and use committee statement: All 
animal experiments were approved by the Thuringian State Office 
of Food Safety and Consumer Protection (Department Consumer 
Protection, Veterinary and Pharmacy, Bad Langensalza, 
Germany). Protocol number: 02-039/12.
Conflict-of-interest statement: All authors have no conflicts of 
interest or financial ties to disclose. 
Data sharing statement: The technical appendix and dataset 
are available from the corresponding author at felix.dondorf@
med.uni-jena.de.
Open-Access: This article is an open-access article which was 
selected by an in-house editor and fully peer-reviewed by external 
reviewers. It is distributed in accordance with the Creative 
Commons Attribution Non Commercial (CC BY-NC 4.0) license, 
which permits others to distribute, remix, adapt, build upon this 
work non-commercially, and license their derivative works on 
different terms, provided the original work is properly cited and 
the use is non-commercial. See: http://creativecommons.org/
licenses/by-nc/4.0/
Manuscript source: Invited manuscript
Correspondence to: Falk Rauchfuß, MD, MSc, Department of 
General, Visceral and Vascular Surgery, Jena University Hospital, 
Am Klinikum 1, 07747 Jena, 
Germany. falk.rauchfuss@med.uni-jena.de  
Telephone: +49-3641-9322601 
Fax: +49-3641-9322602
Received: December 27, 2016
Peer-review started: December 28, 2016
First decision: February 10, 2017
Revised: February 27, 2017
Accepted: May 9, 2017
Article in press: May 9, 2017
Published online: June 21, 2017
Abstract
AIM
To analyze time intervals of inflammation and re-
generation in a cholestatic rat liver model.
METHODS
In 36 Lewis rats, divided into six groups of 6 animals 
(postoperative observation periods: 1, 2, 3, 4, 6, 8 
wk), the main bile duct was ligated with two ligatures 
and observed for the periods mentioned above. 
For laboratory evaluation, cholestasis parameters 
(bilirubin, γ-GT), liver cell parameters (ASAT, ALAT) 
and liver synthesis parameters (quick, albumin) were 
determined. For histological analysis, HE, EvG, ASDCL 
and HMGB-1 stainings were performed. Furthermore, 
we used the mRNA of IL-33, GADD45a and p-21 for 
analyzing cellular stress and regeneration in cholestatic 
rats.
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RESULTS
In chemical laboratory and histological evaluation, 
a distinction between acute and chronic cholestatic 
liver injury with identification of inflammation and 
regeneration could be demonstrated by an increase 
in cholestasis (bilirubin: 1-wk group, 156.83 ± 34.12 
µmol/L, P  = 0.004) and liver cell parameters (ASAT: 
2-wk group, 2.1 ± 2.19 µmol/L.s, P  = 0.03; ALAT: 
2-wk group, 1.03 ± 0.38 µmol/L.s, P  = 0.03) after bile 
duct ligation (BDL). Histological evaluation showed an 
increase of bile ducts per portal field (3-wk group, 48 
± 6.13, P  = 0.004) during the first four weeks after 
bile duct ligation. In addition to inflammation, which 
is an expression of acute cholestasis, there was an 
increase of necrotic areas in the histological sections 
(2-wk group, 1.38% ± 2.28% per slide, P  = 0.002). 
Furthermore, the inflammation could be verified by 
ASDCL (4-wk group, 22 ± 5.93 positive cells per portal 
field, P  = 0.041) and HMGB-1 [2-wk group, 13 ± 
8.18 positive cells per field of view (FoV), P  = 0.065] 
staining. Therefore, in summary of the laboratory 
evaluation and histological studies, acute cholestasis 
could be found during the first four weeks after bile 
duct ligation. Subsequently, the described parameters 
declined so that chronic cholestasis could be assumed. 
For quantification of secondary biliary cirrhosis, eosin 
staining was performed, which did not reveal any signs 
of liver remodeling, thus precluding the development of 
a chronic cholestasis model. Additionally, to establish 
the chronic cholestasis model, we evaluated liver 
regeneration capacity through measurements of IL-33, 
p-21 and GADD45a mRNA.
CONCLUSION
We created a chronic cholestasis model. The point 
of inflammatory and regenerative balance was 
reached after four weeks. This finding should be used 
for experimental approaches dealing with chronic 
cholestatic liver damage.
Key words: Rats; Cholestasis; Chronic cholestasis; Rat 
liver model 
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Animal research models mostly address either 
acute cholestasis or secondary biliary cirrhosis, neither 
of which reflect the clinical reality of central liver 
tumors with cholestatic liver damage without secondary 
liver cirrhosis. In this work, we present our data from a 
model simulating chronic cholestatic liver damage in an 
otherwise healthy liver.
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INTRODUCTION
Liver resection is performed as a first-line treatment 
for certain types of benign and malignant liver 
tumors, especially hepatocellular carcinoma (HCC), 
cholangiocellular carcinoma (CCC) and colorectal liver 
metastases. In most patients, this procedure can be 
performed safely with low morbidity and mortality. 
However, in a subgroup of patients with impaired 
regenerative capacity or in those undergoing extended 
resection, the risk of post-resection liver failure is 
significant[1,2].
Obstructive cholestasis is a well-known risk factor 
for complications after liver surgery. Thus, patients 
with cholestasis, for example, those with cancer 
of the extrahepatic bile ducts, are at greater risk 
for postoperative liver failure, sepsis, and death[3]. 
Cholestasis, which is often a symptom of central 
bile duct carcinoma, considerably disturbs liver 
function and regenerative ability and contributes to 
perioperative morbidity and mortality[4]. The clinical 
situation is usually characterized by subacute or 
chronic cholestasis. Condensed cholestasis increases 
the risk of postoperative hepatic insufficiency[5]. In 
2007, Yokoyama et al[4] presented various theses 
on the pathophysiological background of attenuated 
regenerative response established by cholestasis, 
including decreased portal venous inflow, decreased 
production of proliferation associated factors, 
decreased or absent enterohepatic circulation, and an 
increased rate of apoptosis.
Rodent models have been established especially 
for hepatobiliary surgery experiments focusing on 
extended liver resections, additionally, rat models are 
often used for other experimental procedures, such as 
examination of liver regeneration after BDL (bile duct 
ligation)[6]. For larger animals, logistical, financial, and 
ethical conditions are particularly limiting. Therefore, 
these approaches play a minor role in the experimental 
setting of advanced liver resections[7]. Therefore, most 
of our knowledge about liver regeneration originates 
from studies of rats after 2/3 hepatectomy[7,8]. 
In experimental liver surgery, induction of cholestasis 
with subsequent treatment of liver regeneration is often 
used[9]. It is especially remarkable that models with 
induction of acute cholestasis are used in literature. 
There are no rat models of chronic cholestasis without 
induced secondary biliary cirrhosis found in the current 
literature. 
To consider the acute phase of cholestatic liver 
damage and the transition to chronic hepatic paren-
chymal damage (fibrosis/cirrhosis), the establishment 
of a rat model is essential to approach clinical reality as 
closely as possible.  
MATERIALS AND METHODS
Animals
Male Lewis rats (Charles River, Sulzfeld, Germany) 
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aged 11 ± 1.18 wk, with body weights of 310 ± 27 
g, were kept under standard animal care conditions 
and were fed with rat chow and water ad libitum. Six 
animals were in each group (observation time 1, 2, 3, 4, 
6 and 8 wk).
Surgery 
For the implementation of anesthesia, isoflurane 
(3.0%-4.0%) in combination with oxygen (0.5 L/min) 
was used. After laparotomy, the main bile duct was 
separated and double ligated (Prolene 6-0, Ethicon, 
Norderstedt, Germany) at the liver hilum with secure 
protection of the pancreatic duct.
After the observation period (1, 2, 3, 4, 6 and 8 wk), 
the animals were harvested through blood collection 
(inferior caval vein), hepatectomy and subsequent 
exsanguination under anesthesia. 
Body and liver weights
Animal body weights were measured before the 
operation, during the observation period (daily during 
the first post-operative week, and every second day 
afterwards) and before harvesting. The wet liver 
weight was measured after hepatectomy.
Laboratory measurements
The collected blood was analyzed to obtain the 
following parameters: bilirubin, ASAT, ALAT, γ-GT, 
quick, albumin. Collected blood samples were analyzed 
using ARCHITECT ci16200 (Abbott, Wiesbaden, 
Deutschland) and a Scil Vet ABC Hematology Analyzer 
(Scil Animal Care Company Inc., Viernheim, Germany).
Histologic examination
3-4 µm paraffin-embedded liver sections were stained 
using several methods: H&E (hematoxylin and 
eosin), EvG (van Gieson stain), ASDCL (Naphtol AS-D 
chloroacetate esterase) and HMGB-1 (high-mobility 
group box 1).
The images were scanned by the Digital Slide 
Scanner Nano Zoomer 2.0-HT (Hamamatsu Photonics, 
Herrsching am Ammersee, Germany) and were 
analyzed using the Histologic viewer NDP.view. 2.3.1 
(Hamamatsu Photonics, Herrsching am Ammersee, 
Germany).
Furthermore, the histology examination program 
Histocad Virtual liver (Fraunhofer MEVIS, Bremen, 
Germany) was used[10]. 
mRNA analysis (p-21, GADD45a, IL-33)
Total RNA was isolated from 30 mg of snap frozen 
liver tissues using the RNeasy kit (Qiagen, Basel, 
Switzerland) according to the manufacturer’s ins-
tructions. cDNA was transcribed from 1 µg of RNA 
using M-MLV reverse transcriptase (Invitrogen, Basel, 
Switzerland) with a random hexanucleotide mix (Roche). 
Quantitative real-time PCR was performed using an ABI 
7700 sequence detector (Applied Biosystems, Rotkreuz, 
Switzerland). Primers and probe sequences for all 
genes measured came from ready-to-use kits produced 
by Applied Biosystems (Rotkreuz, Switzerland), 
for which the sequences were not provided. For 
normalization, the housekeeping gene glycerinaldehyd-
3-phosphat-dehydrogenase (GAPDH) was amplified 
in a parallel reaction (5’-ACTGGCATGGCCTTCCG; 
3’-CAGGCGGCACGTCAGATC; Probe - TTCCTACCCCCAAT 
GTGTCCGTCGT).
Ethical consideration
Since this study is an animal research project, an 
institutional review board statement is not needed in 
our institution.
Animal care and use statement
The animal handling protocol was designed to minimize 
pain or discomfort to the animals. The animals were 
acclimatized to laboratory conditions for two weeks 
before experimentation. The animals were kept under 
defined conventional conditions (temperature: 19-21 
℃, humidity: 30%-70%, day-night cycle of 12 h with 
light changes at 6:00 am and 6:00 pm) with up to 
three animals per cage. The conditions were recorded 
hourly by sensor and were personally controlled daily. 
The animals had access to food (1324 TPF - totally 
pathogen-free, Altromin) and water ad libitum. For the 
implementation of anesthesia, isoflurane (3.0%-4.0%) 
was used in combination with oxygen (0.5 L/min). 
All animals were euthanized by exsanguination under 
general anesthesia.
Statistical analysis
Data were presented as the mean ± SD. The results 
were analyzed using the non-parametric Mann-Whitney-
U-Test. Differences between two groups with P values 
< 0.05 were considered statistically significant. For 
analysis, SPSS (IBM; Version 23.0.0.0) was used.
RESULTS
Body weight
The average preoperative body weight was 310 ± 27 g. 
Body weight loss was measured during the immediate 
postoperative course. The minimum body weight was 
286 ± 21 g. Based on the preoperative body weight; a 
body weight loss percentage of 7.62% ± 2.46% was 
calculated. After four days, an increase in weight was 
recorded. Preoperative body weights were reached 
after 15 ± 2.55 d. 
Laboratory measurements 
Laboratory measurements are displayed in Table 1.
Necrosis 
No extensive necrosis was detected in any animals. 
Nevertheless, a dynamic pattern was identified during 
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ASDCL 
Regarding neutrophil infiltration in the portal fields, 
an increase during the first week with maximal 
increase until the second postoperative week could 
be measured. Afterwards, a decrease in neutrophil 
infiltration was shown (Table 1 and Figure 1).
HMGB-1 
Regarding evaluation of the portal fields, an increase 
of HMGB-1 positive cells could be seen during the first 
two weeks. Thereafter, counting revealed a transition 
period until the fourth postoperative week, after which 
a decrease of HMGB-1 positive cells was shown. In 
contrast to the results described above, the HMGB1-
positive cells in liver tissue but not directly located 
near a portal field reached maximum levels seven 
days after BDL with a subsequent continuous decrease 
observed (Table 1 and Figure 1).
IL-33, p-21, GADD45a 
Regarding p-21 mRNA in liver tissue, an increase could 
the period of observation. Specifically, during the 
first three weeks, an increase in the percentage of 
necrosis per section was seen. Subsequently, a decline 
of necrosis at week three was recorded (Table 1 and 
Figure 1). 
Bile ducts 
Quantifying the bile ducts, an increase in the number 
of bile ducts per portal field was seen during the first 
four weeks. Thereafter, from week 4, a decrease in 
recorded bile ducts per portal field was observed (Table 
1, Figures 1 and 2).
Connective tissue/fibrosis/cirrhosis 
To evaluate the formation of biliary cirrhosis, EvG 
staining was performed. During the entire observation 
period, an increase of connective tissue was shown 
with a maximum increase during the 4th wk after BDL. 
Subsequently, during the 6th to 8th wk groups, a slight 
reduction of connective tissue was seen in the liver 
(Table 1 and Figure 1).
Control 7 d 14 d 21 d 28 d 42 d 56 d 
Bilirubin (µmol/L)      2 ± 0 156.83 ± 34.12 37.34 ± 54.39   43.6 ± 61.49        20.5 ± 38.02      20 ± 40.25      2 ± 0
P = 0.004 P = 0.004 P = 0.008 P = 0.429 P = 0.690 P = 1.000
Albumin (g/L)        8.4 ± 0.89   5.83 ± 0.41      7 ± 1.09   7.6 ± 1.34           8 ± 1.22 9.25 ± 0.96        9.2 ± 0.84
P = 0.004 P = 0.052 P = 0.421 P = 0.329 P = 0.690 P = 0.222
Quick (%)       127 ± 3.13      137 ± 10.33  126 ± 5.02  126 ± 8.94       128 ± 4.49      96 ± 30.89       107 ± 4.79
P = 0.052 P = 1.000 P = 0.548 P = 0.429 P = 0.095 P = 0.016
ASAT (µmol/L.s)      0.91 ± 0.06     5.9 ± 0.66   2.1 ± 2.19 4.05 ± 2.55        1.9 ± 1.94 2.06 ± 1.82      1.07 ± 0.23
P = 0.004 P = 0.030 P = 0.008 P = 0.009 P = 0.151 P = 0.095
ALAT (µmol/L.s)      0.74 ± 0.09   2.11 ± 0.29 1.03 ± 0.38 1.95 ± 0.48      1.09 ± 0.18 0.93 ± 0.24      0.96 ± 0.15
P = 0.004 P = 0.030 P = 0.008 P = 0.004 P = 0.310 P = 0.032
γ-GT (µmol/L.s) 0.07 ± 0     0.4 ± 0.09 0.22 ± 0.36 0.35 ± 0.31      0.12 ± 0.11 0.12 ± 0.12 0.07 ± 0
P = 0.004 P = 0.662 P = 0.151 P = 0.662 P = 0.690 P = 1.000
GADD45a (GADD45a/
GAPDH mRNA)
          1 ± 0.58   0.84 ± 0.15 0.91 ± 0.35 3.25 ± 0.36 2.37 ± 1 0.99 ± 0.38        0.9 ± 0.43
P = 0.841 P = 0.931 P = 0.008 P = 0.030 P = 1.000 P = 0.393
p-21 (p21/GAPDH mRNA)           1 ± 0.64 7.06 ± 1.8   7.1 ± 2.55 1.93 ± 1.19      3.04 ± 1.33 1.52 ± 1.44      3.07 ± 1.24
P = 0.008 P = 0.004 P = 0.151 P = 0.009 P = 0.841 P = 0.036
IL-33 (IL33/GAPDH mRNA)           1 ± 0.21 0.91 ± 0.2 1.33 ± 0.44 4.14 ± 1.93      2.41 ± 0.82 2.58 ± 0.17      1.23 ± 0.26
P = 0.841 P = 0.329 P = 0.008 P = 0.004 P = 0.008 P = 0.036
Bile ducts (bile ducts per PF)        8 ± 0.65    17 ± 3.47    48 ± 6.13         14 ± 2.76      4 ± 0.24           5 ± 0.46
P = 0.002 P = 0.004 P = 0.015 P = 0.126 P = 0.004
Necrosis (% per slide)   0.29 ± 0.14 1.38 ± 2.28 1.31 ± 1.03      0.47 ± 0.21 0.09 ± 0.07    0.21 ± 0.2
P = 0.002 P = 0.004 P = 0.065 P = 0.004 P = 0.662
Fibrosis (% per slide)   1.09 ± 0.61 1.3 ± 0.9 1.22 ± 1.33      2.32 ± 1.67 1.76 ± 0.61      1.53 ± 0.83
P = 1.000 P = 1.000 P = 0.132 P = 0.247 P = 1.000
ASDCL (PF) (positive cells 
per PF)
     36 ± 5.38 43 ± 13    34 ± 2.15         22 ± 5.93    11 ± 1.74           6 ± 1.01
P = 0.394 P = 0.931 P = 0.041 P = 0.004 P = 0.004
HMGB-1 (PF) (positive cells 
per PF)
     17 ± 7.07    18 ± 7.67    12 ± 5.91       13 ± 5.2      8 ± 4.39           6 ± 3.78
P = 0.394 P = 0.329 P = 0.310 P = 0.009 P = 0.004
HMGB-1 (SF) (positive cells 
per FoV)
     25 ± 13.1    13 ± 8.18    10 ± 4.17           9 ± 8.43   5.4 ± 3.42           4 ± 3.09
P = 0.065 P = 0.052 P = 0.002 P = 0.009 P = 0.004
Table 1  Group-wise description of mean laboratory measurements + standard deviations (bilirubin, γ-GT, ASAT, ALAT, albumin, 
quick), laboratory measurements + standard deviation of IL-33, p-21 and GADD45a mRNA, mean measurements + standard 
deviation of histology
P values of Mann-Whitney-U-Test (P < 0.05).
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be measured seven days after BDL with a decline in 
p-21 values after four weeks, as seen in Table 1 and 
Figure 3. In contrast to p-21, the levels of GADD45a 
and IL-33 mRNA increased, reaching a peak 21 d after 
BDL (Table 1 and Figure 3).
DISCUSSION
This experimental study aimed to induce chronic 
cholestasis without the development of liver cirrhosis 
in a rodent model. We showed a balance between 
hepatic inflammation and liver regeneration four weeks 
after BDL. Thus, our work provides an important 
contribution to further experimental studies of chronic 
cholestatic liver damage.
Animals were followed up for 1-8 wk. These ob-
servation time points were chosen on the basis of the 
current literature. As described by Georgiev et al[11], 
the best time point to evaluate acute cholestatic liver 
injury after BDL in mice should be after one week. To 
evaluate chronic cholestatic injury after BDL, follow-up 
periods greater than 2 wk were selected. In a review 
by Marques et al[12], BDL was seen as a safer method 
for induction of cirrhosis in the rat compared to the use 
of carbon tetrachloride (CCl4), which induces cirrhosis 
after 4-6 wk. Therefore, to exclude the possible 
transition to secondary biliary cirrhosis (which should 
be avoided in our setting), an observation period of up 
to eight weeks was selected. 
It must be mentioned that there is a difference 
between the results of BDL and BDL + transection 
of the main bile duct. In 1957, Symeonidis et al[13] 
reported that there is a reconstitution of laboratory 
measurements and histologic findings after BDL in rats 
in contrast to the results after BDL with simultaneous 
transection between two ligatures. Wright et al[14] also 
found that there is a reconstitution of biliary flow after 
BDL in the rat. 
Overall, with regard to this methodology, it can 
be stated that bile duct ligation or double bile duct 
ligation with subsequent separation of the bile duct 
between the ligatures would produce more clear 
results. However, there is no clinical relevance because 
in clinical practice, central liver tumors rarely lead to 
Figure 1  Graphics of histologic sections (H&E, EvG, ASDCL, HMGB-1), divided by group. 
7 d
14 d
21 d
28 d
42 d
56 d
H&E                                    EvG                                  ASDCL                                HMGB-1
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rapid and complete occlusion of the extrahepatic bile 
ducts. In contrast, severe stenosis of the bile duct with 
residual flow is seen in clinical practice. Therefore, 
double ligature was performed without transecting 
the bile duct to establish potential relevance to clinical 
practice. In a subsequent study it could be interesting 
to compare both approaches (double ligation vs 
transection) but the direct comparison was not aim of 
the present work.
Measurements and monitoring of body weight 
after BDL showed a regain of body weight 2-4 d 
after BDL and a return to preoperative body weight 
after 15 d. Comparing this with the results of other 
research groups, similar time periods can be seen in 
rats after BDL[15-17]. Regarding liver weight, Geerts 
et al[18] observed an increase one week after BDL in 
a murine model, which was best achieved through 
ductal proliferation. Our data also showed an increase 
after one week with a peak after three weeks. This 
correlated with the bile duct measurements; therefore, 
the hypothesis of ductal proliferation is representative. 
Additionally, Kountouras et al[15] noted an increase 
in bilirubin after BDL, which stabilized around the 
15th postoperative day with subsequent decline. 
Symeonidis et al[13] assessed the same findings in 
1957. In addition to these reports, Abdel-Aziz et al[19] 
detected the same changes in bilirubin after BDL. They 
noticed an acute cholestasis during the first week and 
a significant decline after two weeks of observation.
Regarding the development of cholestasis, it can be 
stated that cholestasis arises acutely during the first 
week after BDL and then changes into a chronic state. 
This was also described in a review by Marques et al[12] 
in 2012. During the development of acute cholestasis, 
transaminases also rose during the observation period. 
Laboratory measurements showed an increase of 
transaminase levels during the first week after BDL, 
and acute liver cell damage was clearly visible by way 
of cholestasis. Similar findings were also generated by 
Woolbright et al[20]. In a study by Lessa et al[21] an 
additional increase of transaminases during the third 
week after BDL was visible (but not significant), which 
was also detectable in our data. This phenomenon 
might be explained by the small number of animals 
in each group. Furthermore, a second process of 
cell injury or regeneration might lead to a release of 
transaminases, as at this time, markers of cellular 
stress and inflammation increased in tissue mRNA 
levels, and histological changes from caused by 
necrotic and regenerative processes were detected. 
In addition to the liver cell damage, hepatic 
synthesis was restricted after BDL due to acute 
cholestasis, as represented by the serum albumin 
levels. Therefore, the results regarding these values 
displayed a reduction in albumin levels seven days 
after BDL, reflecting impaired synthesis due to acute 
cholestasis, with a subsequent increase in values 
over time. Additionally, Krähenbühl et al[17] described 
hypoalbuminemia after BDL in rat with a subsequent 
increase during the observation period. Contrary to 
the impaired albumin synthesis, the values of the 
hepatically metabolized clotting factors, measured by 
the quick value, remained stable throughout the entire 
observation period. 
Histologic analysis, in correlation with the labo-
ratory measurements, revealed inflammation during 
the first four weeks. During this time, levels of the 
proinflammatory cytokine IL-33 increased further, 
with a peak after day 21, followed by decline during 
subsequent weeks.
No significant rate of necrosis could be detected; 
however, a dynamic variation over time could be 
observed, with an increase during the first two 
weeks after BDL. This increase of necrotic areas in 
the stained sections can be seen as an expression 
of acute liver cell damage due to cholestasis. After 
three weeks, the reduction of necrosis can be 
interpreted as a reduction in acute injury caused by 
cholestasis. Additionally, Johnstone et al[22] were able 
to determine the formation of necrosis immediately 
after biliary obstruction, which reversed during follow 
up. Furthermore, the formation of necrosis was 
demonstrated by Prado et al[23] after BDL in mice. 
In the process of biliary obstruction, necrosis is the 
expression of dead liver cells resulting from an acute 
metabolic disorder, which depletes ATP[24].
The results of bile duct quantification with the 
described increase until the first four weeks of 
observation can be seen as a histologic manifestation of 
cholestasis, but the subsequent drop after four weeks 
must be discussed as a reconstitution of biliary flow 
despite BDL. Therefore, according to Steiner et al[25] 
and Cameron et al[26], an insufficient ligature must 
be considered in this discussion. Furthermore, the 
formation of new bile ducts in the area of ligature must 
also be discussed in this context. 
The radiological cholangiography to examine this 
hypothesis was not performed in this study because 
the primary focus was placed on hepatic regeneration 
ability. Accordingly, radiological cholangiography by 
opening the bile ducts would have brought a possible 
change of data.
Wright et al[14] observed the formation of new bile 
Figure 2  Bile duct quantification, mean bile ducts per portal field + 
standard deviations, divided by group. 
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ducts by using contrast agents, both proximal and 
distal to the ligature, and noticed the formation of 
new bile ducts around a sufficient ligature. According 
to the results of the research group, new bile ducts 
formed between the 14th and 20th d postoperatively 
with reconstruction of biliary flow from day 28, which 
is comparable to the findings reported in this work. 
In their review from 2012, Marques et al[12] 
determined that cholestasis occurs two weeks after 
BDL in the rat, and after 4-6 wk, the transition to a 
secondary biliary cirrhosis could be seen. In contrast to 
that, Johnstone et al[22] could not find secondary biliary 
cirrhosis after double ligation of the bile duct after an 
observation period of 40 d. 
The results of this study showed an increase in 
connective tissue during the period of observation with 
an increase in the fourth week, followed by a recorded 
decline in the six and eight-week groups. Overall, 
our findings indicate the incipient reconstruction of 
hepatic tissue after induction of cholestasis without the 
development of fibrosis. 
There was a peak in the number of neutrophil 
granulocytes in the area of the portal fields after 14 
d of observation period using ASDCL staining. This 
supports the hypothesis of an acute inflammatory 
reaction within the first two weeks after BDL, which 
regresses subsequently. 
High mobility group box 1 acts as a mediator 
of early organ damage and inflammation[27]. Thus, 
HMGB-1 will be released from ischemic liver cells to 
mediate inflammation and damage[28]. In this context, 
a translocation of nuclear HMGB-1 can be seen in the 
cytoplasm as an important first step in response to 
damage[27]. Direct injury in the liver parenchyma was 
measured by an increase of HMGB-1 positive cells 
after seven days. 
Comparable to our results, Woolbright et al[20]. 
also detected an increase of HMGB-1 immediately 
after BDL in mice and declared their results as an 
expression of the acute inflammatory response to 
cholestatic liver injury. In the present work, a decline 
of HMGB-1 positive cells was recorded during the 
subsequent observation period. This fact reveals that 
the HMGB-1 cytokine is one of the early responses 
to injury. Following the course of acute inflammation 
as mentioned above, these results clearly show that 
liver regeneration occurs after 2-3 wk during the 
observation period.
The role of p-21 in the regulation of liver regeneration 
is complex and not completely understood[29]. Several 
studies have shown that overexpression of p-21 can 
inhibit liver regeneration[29]. Furthermore, several 
genetic studies in mice confirmed the importance of 
p-21 for the regulation of liver regeneration as well as 
its ability to delay tumor development in the liver[30]. 
We detected an increase of p-21 immediately after 
BDL. We explain this up-regulation as a result of the 
acute cholestatic liver injury. Hui et al[29] demonstrated 
in 2002 that impaired liver regeneration is associated 
with up-regulation of the cyclin dependent kinase 
inhibitor p-21. Additionally, Lehmann et al[31] found 
that p-21 mediates a transient physiological barrier to 
the progression and completion of the cell cycle, thus 
inhibiting liver regeneration. We demonstrated that 
p-21 is a marker for impaired liver regeneration with 
up-regulation immediately after BDL. The decrease 
of p-21 after 14 d could be viewed as the reduction 
of inflammation and a shift to chronic cholestatic liver 
injury with liver regenerative capacity.
The results of the IL-33 and GADD45a mRNA 
in liver tissue after two weeks provide evidence of 
incipient chronic liver tissue damage. In correlation 
with the other recorded parameters, this hypothesis 
can be supported. According to the literature, up-
regulated IL-33 can be seen in acute as well as in 
chronic liver injury. The first step of IL-33 up-regulation 
can be seen in acute liver injury, such that IL-33 has 
a function as an alarm protein[32]. The second up-
regulation of IL-33 is described in chronic liver injury, 
and its positive correlation with liver fibrosis is revealed 
by the up-regulation of collagen expression[32-34]. We 
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Figure 3  Mean laboratory, mean + SD of IL-33 (A), p-21 (B) and GADD45a 
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could confirm these findings: IL-33 increases during 
chronic cholestasis, in correlation with the number 
of bile ducts and the increase of connective tissue 
observed in histological analysis. 
Concerning the acute IL-33 up-regulation during 
the 24-48 h period[34], it must be critically noted that 
this was not addressed due to the study design, in 
which the first time point of measurement occurred 
seven days after BDL. 
The growth arrest and DNA damage 45 (GADD45) 
family genes regulate DNA repair, the cell cycle, 
cell survival, apoptosis, senescence, and DNA de-
methylation within cells under various stress stimuli. 
The GADD45 gene family encodes three proteins: 
GADD45A, GADD45B, and GADD45G[35]. The GADD45 
genes are located on different chromosomes, and their 
cognate proteins are small, highly homologous, and 
localized to both the cell nucleus and cytoplasm[35]. 
The cellular senescence process involves several steps, 
including promotion of DNA damage, generating a 
DNA repair signal, eliciting permanent cell cycle arrest, 
and the final entry into senescence[35]. Therefore, 
according to literature, we conclude that GADD45a is 
part of the cellular senescence pathway. Accordingly, 
the up-regulation of GADD45a in chronic cholestatic 
rats can be seen as a kind of cellular senescence with 
a junction to an early sign of liver fibrosis.
Summarizing the present study in the overall 
context of experimental hepatobiliary surgery, it can 
be held that the work illuminates a significant aspect 
of liver parenchymal remodeling in the cholestatic liver. 
However, there are limitations to the work because the 
considered animal group is not compared with a group 
of BDL + transection. In our opinion, this limitation 
of the experimental setup is not essential toward 
achievement of the primary goal, as the model should 
be representative of chronic cholestasis. In clinical 
practice, chronic cholestasis plays a relevant role in a 
subgroup of patients undergoing liver resection. This 
issue has not yet been investigated in experimental 
designs. This investigation in a rat BDL model has 
revealed the first insights into this problem.
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